CAR T-Cell Immunotherapy Rids Woman of Tough-to-Treat Lupus
Researchers have used genetically tweaked immune system cells to send a woman's severe lupus into remission. (Source: WebMD Health)
Source: WebMD Health - August 5, 2021 Category: Consumer Health News Source Type: news
CAR T-Cell Immunotherapy Rids Woman of Tough-to-Treat Lupus
THURSDAY, Aug. 5, 2021 -- In a first, researchers have used genetically tweaked immune system cells to send a woman ' s severe lupus into remission.
The treatment -- called CAR T-cell therapy -- is already approved in the United States for fighting... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 5, 2021 Category: General Medicine Source Type: news
Arthritis, lupus flares rare after COVID-19 vaccination, study finds
The COVID-19 vaccine rarely causes flares in people with rheumatoid arthritis and lupus, according to a study published Wednesday by the journal Arthritis and Rheumatology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 4, 2021 Category: Consumer Health News Source Type: news
FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy, according to data from three trials.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 2, 2021 Category: Dermatology Tags: Rheumatology News Alert Source Type: news
FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus
2 August 2021 -- AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.1
The approval by the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 2, 2021 Category: Drugs & Pharmacology Source Type: news
COVID Vax Does Not Increase Risk of Flare in Patients With Lupus COVID Vax Does Not Increase Risk of Flare in Patients With Lupus
An international web-based survey found a very low rate of medically confirmed flare post COVID vaccination in nearly 700 participants.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 28, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news
Fifteen years in the making, biotech lands in Bay Area with fresh funding from Hyatt heirs and plan to change direction of inflammatory diseases
Giant drug maker Bristol-Myers Squibb and a string of investment vehicles led by heirs of the Hyatt Hotels fortune invested in a North Bay company tapping deep patient data to move faster to discover and develop drugs against lupus, Crohn's disease and other inflammatory diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 27, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news
SLE Neuropsych Event Etiology Helps Define Predictors, Outcomes SLE Neuropsych Event Etiology Helps Define Predictors, Outcomes
Male sex, active systemic lupus erythematosus, and corticosteroid use were among the factors positively associated with neuropsychiatric events in patients with SLE.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 10, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news
NYUAD study maps nanobody structure, leading to new ways to potentially fight diseases
(New York University) For the first time in the UAE, researchers at NYU Abu Dhabi have used nuclear magnetic resonance techniques to determine the structure of a specific nanobody, Nb23, potentially leading to a better understanding of how this small protein derived from an antibody type, found only in camelids (i.e camels, llamas, and alpacas) and sharks, can fight diseases ranging from rheumatoid arthritis, lupus and psoriasis to lymphoma and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2021 Category: Cancer & Oncology Source Type: news
NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Summer 2021 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities & Related Notices
NIH/HHS News
Subscribe to NICDR News
Science Advances
Grantee News
NIDCR News
NIDCR to Release Report on Oral Health in America
As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions in the prevention an...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news
Accelerating Lupus Drug Discovery & Development: Fireside Chat...
This webinar will feature a discussion of advancements and critical milestones to date in SLE research and drug discovery. It will explore key considerations for improving both research into SLE, as...(PRWeb June 28, 2021)Read the full story at https://www.prweb.com/releases/accelerating_lupus_drug_discovery_development_fireside_chat_with_experts_in_sle_research_upcoming_webinar_hosted_by_xtalks/prweb18034256.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 28, 2021 Category: Pharmaceuticals Source Type: news
Lupus Images Fall Short in Diversity Lupus Images Fall Short in Diversity
Medical resources in general have historically underrepresented patients of color.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 18, 2021 Category: Dermatology Tags: Dermatology News Source Type: news
Dacrocystitis in a Teenager?
Discussion
Tears are produced in the lacrimal gland which resides in the upper outer quadrant of the eye. The tears flow across the eye medially and are collected in the superior and inferior puncta which drain into their respective canaliculi, and these drain into a common canaliculus. Tears then pass through the valve of Rosenmuler into the lacrimal sac where they are collected. Tears then pass through the nasolacrimal duct, through the distal valve of Hasner and into the nasal cavity. Vascular connections are extensive in this anatomic area and veins do not have valves. Therefore infections can spread easily through dir...
Source: PediatricEducation.org - June 14, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
BEAT-LUPUS: Belimumab After Rituximab Delays Severe Flares BEAT-LUPUS: Belimumab After Rituximab Delays Severe Flares
Results from a phase 2b trial are"clearly encouraging" and"support the hypothesis that BAFF [B-cell-activating factor] can drive flares after rituximab," said Michael Ehrenstein, MD.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 4, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news
Add-On Voclosporin Improves Outcome in Lupus Nephritis Add-On Voclosporin Improves Outcome in Lupus Nephritis
Voclosporin plus MMF and low-dose corticosteroids improves renal response rates compared with use of these agents alone in patients with in lupus nephritis, according to a company-funded study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news
